Overview
Lobbying Costs
240,000€
Financial year: Apr 2022 - Mar 2023
Lobbyists (Full time equivalent)
1 Fte (1)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
Kirkland Consulting
EU Transparency Register
371804028416-30 First registered on 21 Sep 2017
Goals / Remit
To provide scientific advice to companies, organisations and regulatory agencies on issues related to genotoxicity testing of chemical substances and interpretation of results.
Main EU files targeted
Clinical trial applications for pharmaceuticals, marketing applications for pharmaceuticals, REACH regulation for chemicals, EFSA assessment of food flavours and ingredients, cosmetics regulation, pesticides regulation, assessment of the safety of natural products (e.g. herbal remedies).
Website
-
People
Total lobbyists declared
1
Employment time Lobbyists 100% 1 Lobbyists (Full time equivalent)
1
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Self-employed individuals
-
Networking
Affiliation
Trustee of the European Environmental Mutagenesis and Genomics Society.
Emeritus Member of the US Environmental Mutagenesis and Genomics Society.
Health and Environmental Sciences Institute (HESI) Genetic Toxicology Technical Committee
Genetic Toxicology Association (USA)
UK Environmental Mutagen SocietyMember organisations
None declared
-
Financial Data
Interests represented
Advances interests of their clients
Closed financial year
Apr 2022 - Mar 2023
Lobbying costs for closed financial year
240,000€
Major contributions in closed year
None declared
Clients for closed financial year
Clients list
Name Proposal Amount titanium dioxide manufacturer's association REACH registration and safety of food colours 50,000€ - 99,999€ Consumer Healthcare Products Association Safety of acetaminophen 0€ - 10,000€ Endura Safety of biocides 0€ - 10,000€ saqual GmbH REACH registration 0€ - 10,000€ Genentech Pharmaceutical pre-clinical safety 0€ - 10,000€ Leveret GmbH Safety of food flavourings 0€ - 10,000€ DSM NUTRITIONAL PRODUCTS Animal feed additive 0€ - 10,000€ biologie servier Safety of pharmaceutical impurities 0€ - 10,000€ vifor ag Safety of pharmaceutical impurities 0€ - 10,000€ kiora pharmaceuticals gmbh Pharmaceutical pre-clinical safety 0€ - 10,000€ Elanco Safety of veterinary medicines 0€ - 10,000€ zentiva k.s. Pharmaceutical pre-clinical safety 0€ - 10,000€ dice alpha, inc. Pharmaceutical pre-clinical safety 0€ - 10,000€ chanel parfums beaute Safety of cosmetic ingredients 0€ - 10,000€ alfred e. tiefenbacher (gmbh & co. kg) Pharmaceutical pre-clinical safety 0€ - 10,000€ EPPA SA Safety of pesticides 0€ - 10,000€ neuron23, inc. Pharmaceutical pre-clinical safety 0€ - 10,000€ orion corporation Pharmaceutical pre-clinical safety 0€ - 10,000€ aligos therapeutics inc. Pharmaceutical pre-clinical safety 0€ - 10,000€ merck sharpe & dohme Pharmaceutical pre-clinical safety 0€ - 10,000€ Clients for current financial year
Clients list
Name empress pharmaceuticals dice alpha inc. aligos therapeutics inc. titanium dioxide industry consortium vifor ag a.vogel ag Tate & Lyle zentiva k.s. Titanium Dioxide Manufacturers Association mironid pharmaceuticals akkeri ndp inc. Leveret GmbH reach monitor remix therapeutics inc. boehringer ingelheim pharma gmbh Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
Kirkland D, Aardema M J, Battersby R V, Beevers C, Burnett K, Burzlaff A, Czich A, Donner E M, Fowler P, Johnston H J, Krug H F, Pfuhler S, Stankowski Jr. L F (2022). A weight of evidence review of the genotoxicity of titanium dioxide (TiO2). Regul. Toxicol. Pharmacol. 136, 105263.
Douglas G R, Beevers C, Gollapudi B, Keig-Shevlin Z, Kirkland D, O’Brien J M, van Benthem J, Yauk C L, Young R R, Marchetti F (2022). Impact of Sampling Time on the Detection of Mutations in Rapidly Proliferating Tissues Using Transgenic Rodent Gene Mutation Models: A Review. Environ. Mol. Mutagen. 63, 376-388.
Beevers C, Uno Y, Meurer K, Hamada S, Hashimoto K, Kirkland D, LeBaron M J, Le Curieux F, Le Hegarat L, Martus H J, Masumura K, Ohyama W, Roberts D J, Vasquez M, Whitwell J, Witt K L (2023). In vivo genotoxicity testing strategies: Report from the 8th International Workshop on Genotoxicity Testing (IWGT). Environ. Mol. Mutagen. doi: 10.1002/em.22578. Epub ahead of print. PMID: 37942839.Other activities
None declared
Meetings
Meetings
None declared